Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TxCell S.A.
DescriptionAutologous collagen type II (COL2)-specific regulatory T cells
Molecular Target Collagen type II (COL2)
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationUveitis
Indication DetailsTreat non-infectious uveitis
Regulatory Designation U.S. - Orphan Drug (Treat non-infectious uveitis);
EU - Orphan Drug (Treat non-infectious uveitis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today